CELLAMARE, Saverio
 Distribuzione geografica
Continente #
NA - Nord America 11.517
EU - Europa 4.177
AS - Asia 3.769
SA - Sud America 899
Continente sconosciuto - Info sul continente non disponibili 375
AF - Africa 138
OC - Oceania 7
Totale 20.882
Nazione #
US - Stati Uniti d'America 11.344
SG - Singapore 1.416
DE - Germania 1.118
CN - Cina 1.014
IT - Italia 911
BR - Brasile 704
SE - Svezia 540
RU - Federazione Russa 467
HK - Hong Kong 414
GB - Regno Unito 268
VN - Vietnam 267
FR - Francia 227
UA - Ucraina 213
FI - Finlandia 189
IN - India 122
BD - Bangladesh 107
CA - Canada 77
AR - Argentina 64
TR - Turchia 53
IQ - Iraq 49
BE - Belgio 47
ID - Indonesia 46
MX - Messico 45
JP - Giappone 44
ZA - Sudafrica 38
ES - Italia 36
CI - Costa d'Avorio 35
CO - Colombia 32
EC - Ecuador 29
PL - Polonia 29
IR - Iran 28
IE - Irlanda 27
PK - Pakistan 27
VE - Venezuela 26
NL - Olanda 25
SA - Arabia Saudita 23
UZ - Uzbekistan 19
PH - Filippine 18
CZ - Repubblica Ceca 17
MA - Marocco 16
AT - Austria 13
CL - Cile 13
MY - Malesia 13
EG - Egitto 12
NP - Nepal 12
JO - Giordania 11
KR - Corea 11
PY - Paraguay 11
JM - Giamaica 10
KZ - Kazakistan 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CH - Svizzera 8
KE - Kenya 8
CR - Costa Rica 7
IL - Israele 7
TN - Tunisia 7
BO - Bolivia 6
ET - Etiopia 6
GE - Georgia 6
PE - Perù 6
AL - Albania 5
DZ - Algeria 5
OM - Oman 5
RO - Romania 5
AU - Australia 4
BB - Barbados 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
EU - Europa 3
GD - Grenada 3
KG - Kirghizistan 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
SR - Suriname 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
DK - Danimarca 2
EE - Estonia 2
LB - Libano 2
MN - Mongolia 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AD - Andorra 1
Totale 20.492
Città #
Dallas 1.800
Fairfield 955
Ashburn 865
Chandler 764
Singapore 742
Woodbridge 717
San Jose 600
Jacksonville 490
Houston 428
Hong Kong 404
Seattle 387
Milan 381
Nyköping 379
Wilmington 338
Ann Arbor 331
Cambridge 326
Beijing 262
Council Bluffs 198
Nanjing 160
Roxbury 151
Lawrence 147
New York 135
Lauterbourg 134
Boardman 130
Bari 120
Rome 114
Des Moines 96
Los Angeles 89
Brooklyn 83
Princeton 79
Ho Chi Minh City 72
Dearborn 71
Santa Clara 71
Helsinki 66
Dong Ket 59
São Paulo 59
Munich 53
Hanoi 51
Nanchang 47
Brussels 45
Jiaxing 45
Inglewood 43
Figino 40
San Diego 40
Buffalo 39
Shenyang 39
Columbus 37
Tokyo 37
Hebei 36
Abidjan 35
London 35
North Bergen 35
Chicago 34
Moscow 34
Atlanta 32
Dublin 27
Montreal 26
Phoenix 26
Guangzhou 25
Rio de Janeiro 24
Frankfurt am Main 23
Johannesburg 23
Paris 23
Jakarta 21
Warsaw 21
Tianjin 20
Belo Horizonte 19
Brasília 19
Changsha 19
Kansas City 19
Orem 19
Turin 19
Washington 19
Baghdad 18
Marseille 18
Porto Alegre 18
San Mateo 18
Shanghai 18
Tashkent 18
Chennai 17
Denver 17
Nuremberg 17
Zhengzhou 17
San Francisco 16
Leawood 15
Manchester 15
Ningbo 15
The Dalles 15
Ardabil 14
Mexico City 14
Stockholm 14
Toronto 14
West Jordan 14
Falkenstein 13
Jinan 13
Augusta 12
Bogotá 12
Boston 12
Jeddah 12
Boydton 11
Totale 13.759
Nome #
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.120
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships 1.090
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 254
Design, synthesis and biological evaluation of indane 2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as b-amyloid aggregation inhibitors 241
A Prospective Repurposing of Dantrolene as a Multitarget Agent for Alzheimer’s Disease 219
Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data 217
BCR-ABL inhibitors in chronic myeloid leukemia: process chemistry and biochemical profile 214
Exploring Basic Tail Modifications of Coumarin-based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-soluble, Brain-permeant Neuroprotective Multitarget Agents 208
Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors 201
Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity 199
Molecular optimization of O-glycoside inhibitors of blood coagulation factors. 198
Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties 197
Mind the Gap ! A Journey towards Computational Toxicology 196
Repositioning of dantrolene for Alzheimer’s disease: new and old biological activities towards AD-related targets. 194
Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Aβ40 aggregation in vitro 194
Annelated medium-sized azaheterocycles as attractive scaffolds for CNS targeted leads. 193
New Azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity 186
Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma 186
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 185
3-benzazecine-based cyclic allene derivatives as highly potent P-glycoprotein inhibitors overcoming doxorubicin multidrug resistance 184
Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways 182
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 181
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 179
Inhibition of α-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 178
(EN) GALLOYL BENZAMIDE-BASED COMPOUNDS AS JNK MODULATORS (FR) COMPOSES A BASE DE GALLOYL BENZAMIDE UTILISES EN TANT QUE MODULATEURS DE JNK 178
Human mitochondrial carnitine acylcarnitine carrier: Molecular target of dietary bioactive polyphenols from sweet cherry (Prunus avium L.) 176
Bridging repair of the abdominal wall in a rat experimental model. Comparison between uncoated and polyethylene oxide-coated equine pericardium meshes 174
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4′-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase 173
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 170
A novel strategy for the treatment of Hodgkin lymphoma 167
Linear Solvation Energy Relationships in Reversed-Phase Liquid Chromatography. Examination of Deltabond C8 as Stationary Phase for Measuring Lipophilicity Parameters 167
X-Ray Crystal Structure, Partitioning Behavior and Molecular Modeling Study of Piracetam-type Nootropics: Insights into the Pharmacophore 167
LFER and CoMFA studies on optical resolution of a-alkyl-a-aryloxyacetic acid methyl esters on DACH-DNB chiral stationary phase 164
Partitioning behaviour of piracetam-type cognition enhancers 163
Anticoagulant activity of new glycoconjugated inhibitors Of factor Xa and thrombin 163
Design, synthesis, biological evaluation, NMR and DFT studies of structurally-simplified trimethoxy benzamides as P-glycoprotein selective inhibitors: the role of molecular flatness 162
Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding 161
Benzenesulfonamides Inhibitors of Carbonic Anhydrase: Study of Their Hydrophobicity by RPLC. QSAR: Quantitative Structure Activity Relationships 157
Protection of dopamine towards autoxidation reaction by encapsulation into non-coated- or chitosan- or thiolated chitosan-coated-liposomes 153
AZEPINO [4,3-b]INDOLE DERIVATIVES AS SELECTIVE INHIBITORS OF HUMAN BUTYRYLCHOLINESTERASE WITH PROTECTIVE EFFECTS AGAINST NMDA-INDUCED NEUROTOXICITY 152
Microfluidic pervaporation of ethanol from radiopharmaceutical formulations 152
Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6′-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N- methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors 151
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase 149
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 146
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration 145
Determination of Lipophilicity and Hydrogen-bond Donor Acidity of Bioactive Sulphonyl-containing Compounds by Reversed-phase HPLC and Centrifugal Partition Chromatography and their Application to Structure-activity Relations 145
Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9 145
Lipophilicity Measurements of Benzenesulfonamide Inhibitors of Carbonic Anhydrase by Reversed-phase HPLC 143
A molecular dynamics study of a sub-nanomolar dual binding site heterodimeric AChE inhibitor. 143
Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors 142
An improved method for the biological evaluation of polyphenol derivatives as potential inhibitors of aβ(1–40) aggregation 142
Pyrrolo(3,2-c)pyridine derivatives as inhibitors of platelet aggregation 136
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 136
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 135
QSAR of Teicoplanin Antibiotics: Influence of Lipophilicity and Ionic Properties on their in vivo Antimicrobial Activity 134
Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 133
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 133
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 132
Benzenesulfonamide inhibitors of carbonic anhydrase: study of their hydrophobicity by RPLC. 131
Inhibiting Aβ1-40 in vitro aggregation by glycine-based molecular tongs: rational design and mechanistic implications 130
Studio dell’Idrolisi Chimica e Plasmatica di Aril-nipecotati ad Attività Gaba-mimetica Attraverso Analisi Regressionale 129
New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity 129
Synthesis and biological evaluation of arylhydrazone derivatives of indoles and indolin-2-ones as b-amyloid aggregation inhibitors 128
Estimation of the Binding Free Energy by Linear Interaction Energy Models 128
Bicyclic dilactam peptides and N-substituted derivatives of cyclic aminoacids as new inhibitors of amyloidogenesis 127
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 127
Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease 125
The effect of Thapsia essential oils on bile composition in rats 124
Toward a fragment-based approach to MMPs inhibitors: an expedite and efficient synthesis of N-hydroxylactams 124
New N-arylmethyl derivatives of some cyclic amino acids and new peptidomimetics: synthesis and inhibition activity of insulin amyloid formation 123
Enantiomeric Resolution of Sulfoxides on a DACH-DNB Chiral Stationary Phase: a Quantitative Structure-Enantioselective Retention Relationship (QSERR) Study 123
Synthesis and anticonvulsant activity of some 1,2,3,3a-tetrahydropyrrolo[2,1-b]-benzothiazol-, -thiazol- or -oxazol-1-ones in rodents. 122
Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded gucocorticoid after aerosolization in mice 122
Design, synthesis and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors 120
Isatin 3-arylhydrazones: from inhibitors of amyloidogenesis to multitarget agents with potential in Alzheimer’s disease. 118
QSAR of Teicoplanin Antibiotics: Influence of Lipophilicity and Ionic Properties on their in vivo Antimicrobial Activity 116
Design, Synthesis and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium-like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors 116
Direct chromatographic resolution of carnitine and O-acylcarnitine enantiomers on a teicoplanin-bonded chiral stationary phase 114
Teicoplanin-based enantiomeric separations in CZE using a partial filling technique 113
Development and analytical characterization of vitamin(s)-loaded chitosan nanoparticles for potential food packaging applications 113
Increased bile acid excretion and reduction of serum cholesterol after crenotherapy with salt-rich mineral water 113
Derivatives of annulated tetrahydroazocines and tetrahydroazonines as cholinesterase inhibitors 113
Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides 113
Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein. 111
Inhibition of uptake of [3H] dopamine into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 110
Toxicity to P12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 108
Nose-to-brain delivery: a comparative study between carboxymethyl chitosan based conjugates of dopamine 108
Synthesis and biological evaluation of arylhydrazone derivatives of indoles and indolin-2-ones as β-amyloid aggregation inhibitors 107
Antiplatelet activity of nipecotic acid derivatives 107
Solid Phase Synthesis of Safinamide and Analogues as Potent and Selective MAO-B Inhibitors 107
Synthesis and biological evaluation of Mannich base derivatives of the neuroprotective 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3- b]indol-1(2H)-one 105
Insight into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 105
Thermodynamic Parameters, X-ray Structure, and QSAR Studies of Condensed Diazines as MAO Inhibitors 105
Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships 105
Inhibiting Aβ1-40 in vitro aggregation by glycine-based molecular tongs: rational design and mechanistic implications 104
Coumarin as a versatile scaffold to selectively target biologically relevant cytochrome P450 enzymes: aromatase, steroid 11β-hydroxylase and aldosterone synthase 104
Effect of Thapsia essential oils on bile composition in rats 103
Substituent effects on the enantioselective retention of anti-HIV 5-aryl-delta 2-1,2,4-oxadiazolines on R,R-DACH-DNB chiral stationary phase. 103
Oxazolidinone Amide Antibiotics 103
OPTIMIZATION OF COUMARIN-BASED MULTITARGET LIGANDS: DISCOVERY OF POTENT WATER-SOLUBLE AND BRAINPERMEANT NEUROPROTECTIVE AChE-MAO B INHIBITORS 103
Totale 16.624
Categoria #
all - tutte 72.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.736


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022934 0 0 24 50 35 65 61 44 72 114 191 278
2022/20231.976 307 202 121 172 312 210 21 234 308 22 40 27
2023/2024755 54 113 40 94 58 146 33 27 30 22 20 118
2024/20252.414 77 57 229 110 61 170 211 221 133 104 332 709
2025/20267.105 710 546 1.681 628 543 286 581 209 566 444 228 683
2026/2027645 140 259 246 0 0 0 0 0 0 0 0 0
Totale 20.882